Company page

Samsung Biologics Co., Ltd.

Samsung Biologics Co., Ltd. is a leading biopharmaceutical company based in South Korea, with a market capitalization of approximately 42.76 trillion KRW. The company specializes in contract manufacturing and development services for biopharmaceutical products. As a key player in the biotechnology sector, Samsung Biologics is committed to advancing healthcare solutions through innovative biomanufacturing processes.

profile207940:KRXAI content: aiUpdated June 24, 2026/company/samsung-biologics-co-ltd/c-jsufuunk
Samsung Biologics Co., Ltd. logo
Ticker
207940:KRX
Asset type
Stock
Market cap
$42.76B
Sector
Health Technology
Industry
Biotechnology
Exchange
KRX
Currency
KRW